交易中 09-20 11:49:25 美东时间
-0.150
-0.33%
Protagonist Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $40 Fro...
08-07 18:10
Protagonist Therapeutics (NASDAQ:PTGX) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.69) by 27.54 percent. This is a 26.47 percent increase over losses of $(0.68) per
08-06 19:52
Protagonist Therapeutics shares are trading lower. The company reported Q2 fina...
08-06 19:50
Protagonist Therapeutics Q2 Basic EPS USD -0.5
08-06 19:02
Protagonist Therapeutics Q2 Net Income USD -30.616 Million Vs. IBES Estimate US...
08-06 19:02
咨询方案提供商QXO涨超56.3%,近日宣布了一项定向增发融资;新股OneStream首日收涨34.2%>>
07-25 19:41
Protagonist Therapeutics Inc : JP Morgan Raises Target Price to $48 From $39
07-25 12:28
U.S. stocks were lower, with the Dow Jones index falling around 350 points on W...
07-24 22:46
Protagonist Therapeutics Inc : Btig Raises Target Price to $51 From $41
07-24 12:42
PTGX: 11% | Protagonist Therapeutics To Join S&P SmallCap 600, Effective Prior To Opening Of Trading On July 3 DJT: 16% | Trump Media & Technology Group shares are trading higher following
06-28 20:37